References
- WongWLSuXLiXGlobal prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysisLancet Glob Health201422e106e11625104651
- FerrisFLWilkinsonCPBirdAClinical classification of age-related macular degenerationOphthalmology2013120484485123332590
- The Age-Related Eye Disease Study Research GroupThe Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study report number 6Am J Ophthalmol2001132566868111704028
- KleinRKleinBEMossSEAge-related eye disease and survival. The Beaver Dam Eye StudyArch Ophthalmol199511333333397887847
- SunnessJSRubinGSZuckerbrodAApplegateCAFoveal-sparing scotomas in advanced dry age-related macular degenerationJ Vis Impair Blind20081021060061020224750
- RudnickaARKapetanakisVVJarrarZIncidence of late-stage age-related macular degeneration in American whites: systematic review and meta-analysisAm J Ophthalmol2015160185.e8393.e8325857680
- OwenCGFletcherAEDonoghueMRudnickaARHow big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?Br J Ophthalmol200387331231712598445
- OwenCGJarrarZWormaldRCookDGFletcherAERudnickaARThe estimated prevalence and incidence of late stage age related macular degeneration in the UKBr J Ophthalmol201296575275622329913
- Age-related Eye Disease Study GroupA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Arch Ophthalmol2001119101417143611594942
- ChewEYClemonsTESangiovanniJPSecondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report no. 3JAMA Ophthalmol2014132214214924310343
- GassJDDrusen and disciform macular detachment and degenerationArch Ophthalmol19739032062174738143
- SarksSHDrusen patterns predisposing to geographic atrophy of the retinal pigment epitheliumAust J Ophthalmol198210291977103872
- SarksJPSarksSHKillingsworthMCEvolution of geographic atrophy of the retinal pigment epitheliumEye19882Pt 55525772476333
- SunnessJSThe natural history of geographic atrophy, the advanced atrophic form of age-related macular degenerationMol Vis199952510562649
- SunnessJSGonzalez-BaronJApplegateCAEnlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degenerationOphthalmology199910691768177910485549
- Schmitz-ValckenbergSFleckensteinMHelbHMCharbel IssaPSchollHPHolzFGIn-vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degenerationInvest Ophthalmol Vis Sci20095083915392119339734
- MelethADMettuPAgronEChanges in retinal sensitivity in geographic atrophy progression as measured by microperimetryInvest Ophthalmol Vis Sci20115221119112620926818
- SunnessJSApplegateCAHaselwoodDRubinGSFixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt diseaseOphthalmology19961039145814668841306
- SunnessJSRubinGSApplegateCAVisual function abnormalities and prognosis in eyes with age-related geographic atrophy of the macula and good visual acuityOphthalmology199710410167716919331210
- SeddonJMReynoldsRMallerJFagernessJADalyMJRosnerBPrediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variablesInvest Ophthalmol Vis Sci20095052044205319117936
- KleinMLFerrisFL3rdFrancisPJProgression of geographic atrophy and genotype in age-related macular degenerationOphthalmology201011781554155920381870
- GrassmanFFauserSWeberBThe genetics of age-related macular degeneration (AMD) – novel targets for designing treatment options?Eur J Pharm Biochem Epub5162015
- LiuMMChanCCTuoJGenetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial geneticsHum Genomics201261132123244519
- GrassmannFFleckensteinMChewEYClinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degenerationPLoS One2015105e012663625962167
- CaireJRecaldeSVelazquez-VilloriaAGrowth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degenerationJAMA Ophthalmol2014132552853424557084
- JohnsonLVOzakiSStaplesMKEricksonPAAndersonDHA potential role for immune complex pathogenesis in drusen formationExp Eye Res200070444144910865992
- JohnsonLVLeitnerWPStapelsMKComplement activation and inflammatory processes in Drusen formation and age related macular degenerationExp Eye Res200173688789611846519
- KeenanTDPickfordCEHolleyRJAge-dependent changes in heparan sulfate in human Bruch’s membrane: implications for age-related macular degenerationInvest Ophthalmol Vis Sci20145585370537925074778
- BhuttoILuttyGUnderstanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complexMol Aspects Med201233429531722542780
- HagemanGSLuthertPJVictor ChongNHJohnsonLVAndersonDHMullinsRFAn integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degenerationProg Retin Eye Res200120670573211587915
- AndersonDHMullinsRFHagemanGSA role for local inflammation in the formation of drusen in the aging eyeAm J Ophthalmol2002134341143112208254
- MullinsRFSkeieJMMaloneEAKuehnMHMacular and peripheral distribution of ICAM-1 in the human choriocapillaris and retinaMol Vis20061222423516604055
- BoraPSSohnJHCruzJMRole of complement and complement membrane attack complex in laser-induced choroidal neovascularizationJ Immunol2005174149149715611275
- BoraNSKaliappanSJhaPComplement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor HJ Immunol200617731872187816849499
- NozakiMRaislerBJSakuraiEDrusen complement components C3a and C5a promote choroidal neovascularizationProc Natl Acad Sci U S A200610372328233316452172
- CurcioCAMessingerJDSloanKRMcGwinGMedeirosNESpaideRFSubretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis modelRetina201333226527623266879
- ZanzotteraECMessingerJDAchTSmithRTCurcioCASubducted and melanotic cells in advanced age-related macular degeneration are derived from retinal pigment epitheliumInvest Ophthalmol Vis Sci20155653269327826024109
- CurcioCAMedeirosNEMillicanCLPhotoreceptor loss in age-related macular degenerationInvest Ophthalmol Vis Sci1996377123612498641827
- KleinMLFerrisFLArmstrongJRetinal precursors and the development of geographic atrophy in age-related macular degenerationOphthalmology200811561026103117981333
- Group CoA-rMDPTCRRisk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trialOphthalmology20081159147414791479.e14711476.e147118502512
- YingGSMaguireMGDevelopment of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trialOphthalmology2011118233233820801521
- DavisMDGangnonRELeeLYThe Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17Arch Ophthalmol2005123111484149816286610
- YingGSMaguireMGAlexanderJMartinRWAntoszykANDescription of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-Related Macular Degeneration Prevention trialArch Ophthalmol200912791147115119752423
- FerrisFLDavisMDClemonsTEA simplified severity scale for age-related macular degeneration: AREDS report no. 18Arch Ophthalmol2005123111570157416286620
- MarsigliaMBodduSBearellySAssociation between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degenerationInvest Ophthalmol Vis Sci201354127362736924114542
- HolzFGStraussECSchmitz-ValckenbergSvan Lookeren CampagneMGeographic atrophy: clinical features and potential therapeutic approachesOphthalmology201412151079109124433969
- KleinRMeuerSMKnudtsonMDIyengarSKKleinBEThe epidemiology of retinal reticular drusenAm J Ophthalmol2008145231732618045568
- HolzFGSteinbergJSGöbelAFleckensteinMSchmitz-ValckenbergSFundus autofluorescence imaging in dry AMD: 2014 Jules Gonin lecture of the Retina Research FoundationGraefes Arch Clin Exp Ophthalmol2015253171625408425
- SparrowJRDunckerTFundus autofluorescence and RPE lipofuscin in age-related macular degenerationJ Clin Med2014341302132125774313
- SparrowJRYoonKWuYYamamotoKInterpretations of fundus autofluorescence from studies of the bisretinoids of the retinaInvest Ophthalmol Vis Sci20105194351435720805567
- FleckensteinMSchmitz-ValckenbergSLindnerMThe “diffuse-trickling” fundus autofluorescence phenotype in geographic atrophyInvest Ophthalmol Vis Sci20145552911292024699379
- RudolfMVogtSDCurcioCAHistologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophyOphthalmology2013120482182823357621
- SunnessJSApplegateCABresslerNMHawkinsBSDesigning clinical trials for age-related geographic atrophy of the macula: enrollment data from the geographic atrophy natural history studyRetina200727220421017290203
- Garcia FilhoCAYehoshuaZGregoriGChange in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degenerationOphthalmic Surg Lasers Imaging Retina2014451183124354307
- CsakyKGRichmanEAFerrisFLIIIReport from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints SymposiumInvest Ophthalmol Vis Sci200849247948918234989
- KleinRDavisMDMagliYLSegalPKleinBEHubbardLThe Wisconsin age-related maculopathy grading systemOphthalmology1991987112811341843453
- BirdACBresslerNMBresslerSBAn international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study GroupSurv Ophthalmol19953953673747604360
- KleinRKleinBELintonKLPrevalence of age-related maculopathy. The Beaver Dam Eye StudyOphthalmology19929969339431630784
- SunnessJSBresslerNMTianYAlexanderJApplegateCAMeasuring geographic atrophy in advanced age-related macular degenerationInvest Ophthalmol Vis Sci19994081761176910393046
- LindbladASLloydPCClemonsTEChange in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26Arch Ophthalmol200912791168117419752426
- SchollHPDandekarSSPetoTWhat is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration?Ophthalmology2004111112513214711724
- van LeeuwenRChakravarthyUVingerlingJRGrading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35 mm film?Ophthalmology20031101540154412917169
- DanisRPDomalpallyAChewEYMethods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 report number 2)Invest Ophthalmol Vis Sci20135474548455423620429
- HubbardLDDanisRPNeiderMWBrightness, contrast, and color balance of digital versus film retinal images in the Age-Related Eye Disease Study 2Invest Ophthalmol Vis Sci20084983269328218421079
- von RuckmannAFitzkeFWBirdACDistribution of fundus auto-fluorescence with a scanning laser ophthalmoscopeBr J Ophthalmol19957954074127612549
- von RuckmannAFitzkeFWBirdACFundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscopeInvest Ophthalmol Vis Sci19973824784869040481
- HolzFGBellmanCStaudtSSchuttFVolckerHEFundus autofluorescence and development of geographic atrophy in age-related macular degenerationInvest Ophthalmol Vis Sci20014251051105611274085
- Schmitz-ValckenbergSJorzikJUnnebrinkKHolzFGAnalysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degenerationGraefes Arch Clin Exp Ophthalmol20022402737811933894
- RamseyDJSunnessJSMalviyaPApplegateCHagerGDHandaJTAutomated image alignment and segmentation to follow progression of geographic atrophy in age-related macular degenerationRetina20143471296130724398699
- Schmitz-ValckenbergSBrinkmannCKAltenFSemiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degenerationInvest Ophthalmol Vis Sci201152107640764621873669
- HolzFGBellmannCMargaritidisMSchuttFOttoTPVolckerHEPatterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degenerationGraefes Arch Clin Exp Ophthalmol199923721451529987631
- Schmitz-ValckenbergSBindewald-WittichADolar-SzczasnyJCorrelation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMDInvest Ophthalmol Vis Sci20064762648265416723482
- BearellySKhanifarAALedererDEUse of fundus autofluorescence images to predict geographic atrophy progressionRetina2011311818620890245
- BindewaldABirdACDandekarSSClassification of fundus autofluorescence patterns in early age-related macular diseaseInvest Ophthalmol Vis Sci20054693309331416123434
- HolzFGBindewald-WittichAFleckensteinMDreyhauptJSchollHPSchmitz-ValckenbergSProgression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degenerationAm J Ophthalmol2007143346347217239336
- Wolf-SchnurrbuschUEWittwerVVGhanemRBlue-light versus green-light autofluorescence: lesion size of areas of geographic atrophyInvest Ophthalmol Vis Sci201152139497950222110076
- SpaideRFFundus autofluorescence and age-related macular degenerationOphthalmology2003110239239912578786
- Schmitz-ValckenbergSFleckensteinMGobelAPEvaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophyAm J Ophthalmol2008146218319218514607
- ParkSPSiringoFSPensecNComparison of fundus autofluorescence between fundus camera and confocal scanning laser ophth almoscope-based systemsOphthalmic Surg Lasers Imaging Retina201344653654324221461
- WuZLuuCDAytonLNOptical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degenerationOphthalmology2014121122415242225109931
- SimaderCSayeghRGMontuoroAA longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophyAm J Ophthalmol20141583557566.e55124879944
- NunesRPGregoriGYehoshuaZPredicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retinaOphthalmic Surg Lasers Imaging Retina201344434435923883530
- MoussaKLeeJYStinnettSSJaffeGJSpectral domain optical coherence tomography-determined morphologic predictors of the age-related macular degeneration-associated geographic atrophy progressionRetina20133381590159923538573
- FleckensteinMSchmitz-ValckenbergSMartensCFundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophyInvest Ophthalmol Vis Sci20115263761376621310912
- HaririANittalaMGSaddaSROuter retinal tubulation as a predictor of the enlargement amount of geographic atrophy in age-related macular degenerationOphthalmology2015122240741325315664
- CohenSYDuboisLNghiem-BuffetSRetinal pseudocysts in age-related geographic atrophyAm J Ophthalmol20101502211217.e21120537310
- MonesJBiarnesMTrindadeFHyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: an underreported findingOphthalmology201211971412141922440276
- ForteRQuerquesGQuerquesLLevezielNBenhamouNSouiedEHMultimodal evaluation of foveal sparing in patients with geographic atrophy due to age-related macular degenerationRetina201333348248923400084
- YehoshuaZGarcia FilhoCAPenhaFMComparison of geographic atrophy measurements from the OCT fundus image and the sub-RPE slab imageOphthalmic Surg Lasers Imaging Retina201344212713223510038
- SchacharIHZahidSComerGMQuantification of fundus autofluorescence to detect disease severity in nonexudative age-related macular degenerationJAMA Ophthalmol201313181009101523787960
- WuZLuuCDAytonLNFundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degenerationInvest Ophthalmol Vis Sci20155631546155225678689
- SchutzeCBolzMSayeghRLesion size detection in geographic atrophy by polarization-sensitive optical coherence tomography and correlation to conventional imaging techniquesInvest Ophthalmol Vis Sci201354173974523258154
- PanorgiasAZawadzkiRJCappsAGHunterAAMorseLSWernerJSMultimodal assessment of microscopic morphology and retinal function in patients with geographic atrophyInvest Ophthalmol Vis Sci20135464372438423696601
- GochoKSardaVFalahSAdaptive optics imaging of geographic atrophyInvest Ophthalmol Vis Sci20135453673368023620431
- HwangJCChanJWChangSSmithRTPredictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degenerationInvest Ophthalmol Vis Sci20064762655266116723483
- BatiogluFGedik OguzYDemirelSOzmertEGeographic atrophy progression in eyes with age-related macular degeneration: role of fundus autofluorescence patterns, fellow eye and baseline atrophy areaOphthalmic Res2014522535924993093
- SunnessJSMargalitESrikumaranDThe long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trialsOphthalmology2007114227127717270676
- DomalpallyADanisRPWhiteJCircularity index as a risk factor for progression of geographic atrophyOphthalmology2013120122666267124206616
- KleinRMeuerSMKnudtsonMDKleinBEThe epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye studyAm J Ophthalmol2008146569269918672224
- BiarnesMAriasLAlonsoJIncreased fundus autofluorescence and progression of geographic atrophy secondary to age-related macular degeneration: the GAIN studyAm J Ophthalmol20151602345353.e525982972
- YehoshuaZde Amorim Garcia FilhoCANunesRPComparison of geographic atrophy growth rates using different imaging modalities in the COMPLETE studyOphthalmic Surg Lasers Imaging Retina201546441342225970861
- DreyhauptJMansmannUPritschMDolar-SzczasnyJBindewaldAHolzFGModelling the natural history of geographic atrophy in patients with age-related macular degenerationOphthalmic Epidemiol200512635336216283987
- FeuerWJYehoshuaZGregoriGSquare root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of Age-Related Eye Disease Study report no. 26JAMA Ophthalmol2013131111011123307222
- LeeSChenTTBarberCLAutocrine VEGF signaling is required for vascular homeostasisCell2007130469170317719546
- Saint-GeniezMKuriharaTSekiyamaEMaldonadoAED’AmorePAAn essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillarisProc Natl Acad Sci U S A200910644187511875619841260
- NishijimaKNgYSZhongLVascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injuryAm J Pathol20071711536717591953
- RosenfeldPJShapiroHTuomiLCharacteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trialsOphthalmology2011118352353020920825
- BhisitkulRBMendesTSRofaghaSMacular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP studyAm J Ophthalmol20151595915924.e91225640411
- GrunwaldJEDanielEHuangJRisk of geographic atrophy in the comparison of age-related macular degeneration treatments trialsOphthalmology2014121115016124084496
- GrunwaldJEPistilliMYingGSGrowth of geographic atrophy in the comparison of age-related macular degeneration treatments trialsOphthalmology2015122480981625542520
- TanakaEChaikitmongkolVBresslerSBBresslerNMVision-threatening lesions developing with longer-term follow-up after treatment of neovascular age-related macular degenerationOphthalmology2015122115316125283060
- DoDVPieramiciDJvan Lookeren CampagneMA phase Ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophyRetina201434231332023842100
- RohrerBGuoYKunchithapauthamKGilkesonGSEliminating complement factor D reduces photoreceptor susceptibility to light-induced damageInvest Ophthalmol Vis Sci200748115282528917962484
- WilliamsDFMAHALO Phase II study: Safety, tolerability and activity of lampalizumab (anti-factor D) in patients with geographic atrophyPaper presented at: American Society of Retinal SpecialistsAugust 27, 2013Toronto, Ontario, Canada
- PatelHREichenbaumDGeographic atrophy: clinical impact and emerging treatmentsOphthalmic Surg Lasers Imaging Retina201546181325559503
- YehoshuaZde Amorim Garcia FilhoCANunesRPSystemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE studyOphthalmology2014121369370124289920
- WongWTDresnerSForooghianFTreatment of geographic atrophy with subconjunctival sirolimus: results of a phase I/II clinical trialInvest Ophthalmol Vis Sci20135442941295023548622
- ZhouHZhaoXJohnsonEJSerum carotenoids and risk of age-related macular degeneration in a Chinese population sampleInvest Ophthalmol Vis Sci20115274338434421508112
- PetrouPACunninghamDShimelKIntravitreal sirolimus for the treatment of geographic atrophy: results of a phase I/II clinical trialInvest Ophthalmol Vis Sci201556133033825525171
- RaduRAMataNLNusinowitzSLiuXSievingPATravisGHTreatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt’s macular degenerationProc Natl Acad Sci U S A200310084742474712671074
- MataNLLichterJBVogelRHanYBuiTVSingermanLJInvestigation of oral fenretinide for treatment of geographic atrophy in age-related macular degenerationRetina201333349850723023528
- ZhouJJangYPKimSRSparrowJRComplement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epitheliumProc Natl Acad Sci U S A200610344161821618717060630
- RaduRAHanYBuiTVReductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseasesInvest Ophthalmol Vis Sci200546124393440116303925
- KubotaRAl-FayoumiSMallikaarjunSPatilSBavikCChandlerJWPhase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteersRetina201434360360924056528
- KubotaRBomanNLDavidRMallikaarjunSPatilSBirchDSafety and effect on rod function of ACU-4429, a novel small-molecule visual cycle modulatorRetina201232118318821519291
- TanitoMLiFElliottMHDittmarMAndersonREProtective effect of TEMPOL derivatives against light-induced retinal damage in ratsInvest Ophthalmol Vis Sci20074841900190517389526
- WongWTKamWCunninghamDTreatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trialInvest Ophthalmol Vis Sci201051126131613920574018
- ChewEYClemonsTEAgrónELong-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35Ophthalmology2013120816041611.e160423582353
- JohnsonLVLeitnerWPRivestAJStaplesMKRadekeMJAndersonDHThe Alzheimer’s A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degenerationProc Natl Acad Sci U S A20029918118301183512189211
- DingJDJohnsonLVHerrmannRAnti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degenerationProc Natl Acad Sci U S A201110828E279E28721690377
- DamicoFMGasparinFScolariMRPedralLSTakahashiBSNew approaches and potential treatments for dry age-related macular degenerationArq Bras Oftalmol2012751717622552424
- LaiRKChunTHassonDLeeSMehrbodFWheelerLAlpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the ratVis Neurosci200219217518512385629
- TattonWChenDChalmers-RedmanRWheelerLNixonRTattonNHypothesis for a common basis for neuroprotection in glaucoma and Alzheimer’s disease: anti-apoptosis by alpha-2-adrenergic receptor activationSurv Ophthalmol200348Suppl 1S25S3712852432
- AllerganSafety and efficacy of brimonidine intravitreal implant in patients with geographic atrophy due to age-related macular degeneration (AMD) [updated: March 13, 2013]. Available from: https://clini-caltrials.gov/ct2/show/results/NCT00658619?sect=X870156&term=NCT00658619&rank=1#outcome2. NLM identifier: NCT00658619Accessed October 8, 2015
- LaVailMMYasumuraDMatthesMTProtection of mouse photoreceptors by survival factors in retinal degenerationsInvest Ophthalmol Vis Sci19983935926029501871
- TaoWWenRGoddardMBEncapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosaInvest Ophthalmol Vis Sci200243103292329812356837
- SievingPACarusoRCTaoWCiliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implantsProc Natl Acad Sci U S A2006103103896390116505355
- ZhangKHopkinsJHeierJSCiliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degenerationProc Natl Acad Sci U S A2011108156241624521444807
- MuYZhaoMSuGStem cell-based therapies for age-related macular degeneration: current status and prospectsInt J Clin Exp Med20147113843385225550892
- LundRDWangSKlimanskayaIHuman embryonic stem cell-derived cells rescue visual function in dystrophic RCS ratsCloning Stem Cells20068318919917009895
- SchwartzSDHubschmanJPHeilwellGEmbryonic stem cell trials for macular degeneration: a preliminary reportLancet2012379981771372022281388
- SchwartzSDRegilloCDLamBLHuman embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studiesLancet2015385996750951625458728